These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6610369)

  • 1. [Hemorrhagic complications of anticoagulants (heparin and dicoumarins) in the treatment of deep venous thrombosis. Report of 176 consecutive patients].
    Lozano F; Ramos M; Morán M; Almazán A; Ingelmo A; Gómez Alonso A
    Angiologia; 1984; 36(3):118-20. PubMed ID: 6610369
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bleeding complications in peroral anticoagulant therapy. A retrospective study of the importance of drug synergism].
    Alexanderson B; Taube A; Westerholm B
    Lakartidningen; 1971 Mar; 68():Suppl I:35+. PubMed ID: 5314654
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastrointestinal hemorrhages under anticoagulant treatment].
    Labayle JM; Bodin F; Lichtenstein H; Conte M
    Sem Hop; 1974 Mar; 50(14):941-5. PubMed ID: 4372685
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulant treatment and digestive hemorrhages].
    Himbert J; Sée E; Thiroloix P; Lenègre J
    Ann Med Interne (Paris); 1971 Nov; 122(11):1055-64. PubMed ID: 5317109
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemorrhagic complications of anticoagulant therapy.
    Coon WW; Willis PW
    Arch Intern Med; 1974 Mar; 133(3):386-92. PubMed ID: 4544112
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coumarin necrosis].
    Jost P
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1069-77. PubMed ID: 5351141
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH; Stier WD; Brunswig D
    Arzneimittelforschung; 1969 Nov; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract]   [Full Text] [Related]  

  • 8. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
    Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soft tissue necrosis and gangrene complicating treatment with the coumarin derivatives.
    Bahadir I; James EC; Fedde CW
    Surg Gynecol Obstet; 1977 Oct; 145(4):497-500. PubMed ID: 897971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral venous and sinus thrombosis treatment with anticoagulants (author's transl)].
    Dörstelmann D; Dobiasch H; Mattes W; Reuther R
    Nervenarzt; 1981 Apr; 52(4):243-6. PubMed ID: 7231625
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration.
    Fagher B; Lundh B
    Acta Med Scand; 1981; 210(5):357-61. PubMed ID: 7039244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 16. Case study: complications associated with anticoagulant therapy.
    Davis GL; Mutnick AH
    Am J Med Technol; 1981 Mar; 47(3):179-82. PubMed ID: 7223763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis].
    Svensson P; Lethagen S; Lindén E; Berntorp E
    Lakartidningen; 1994 Aug; 91(34):2950-2. PubMed ID: 7990537
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of general and hemorrhagic complications after treatment of acute proximal deep venous thrombosis of the legs treated with anticoagulants, streptokinase and thrombectomy].
    Meissner AJ; Misiak A; Huszcza S; Ziemski JM
    Pol Merkur Lekarski; 2000 Nov; 9(53):767-71. PubMed ID: 11204326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Penner J
    N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.